Acer Therapeutics Inc (NASDAQ:ACER)

18.97
Delayed Data
As of 3:59pm ET
 -0.01 / -0.05%
Today’s Change
5.70
Today|||52-Week Range
22.63
+36.97%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Acer Therapeutics Inc have a median target of 60.00, with a high estimate of 70.00 and a low estimate of 50.00. The median estimate represents a +216.29% increase from the last price of 18.97.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in Acer Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.74
Sales
$0.00
Reporting Date
Aug 13

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -38.99%
 
 
 
 
 
 
Growthannually 38.48%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.